Literature DB >> 19523188

Nasty or nice? A perspective on the use of health technology assessment in the United Kingdom.

Michael Drummond1, Corinna Sorenson.   

Abstract

Mesh:

Year:  2009        PMID: 19523188     DOI: 10.1111/j.1524-4733.2009.00552.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  8 in total

1.  Pharmacoeconomic evaluation in Ireland: a review of the process.

Authors:  Lesley Tilson; Aisling O'Leary; Cara Usher; Michael Barry
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approach.

Authors:  Gregory Klein; Laura S Gold; Sean D Sullivan; Diana S M Buist; Scott Ramsey; Karma Kreizenbeck; Kyle Snell; Elizabeth Trice Loggers; Joseph Gifford; John B Watkins; Larry Kessler
Journal:  J Comp Eff Res       Date:  2012-05       Impact factor: 1.744

3.  Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?

Authors:  Nigel Sb Rawson; John Adams
Journal:  Clinicoecon Outcomes Res       Date:  2017-11-22

4.  Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status.

Authors:  N Maniadakis; G Kourlaba; J Shen; A Holtorf
Journal:  BMC Health Serv Res       Date:  2017-05-25       Impact factor: 2.655

5.  How Useful Are Early Economic Models? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling".

Authors:  James Love-Koh
Journal:  Int J Health Policy Manag       Date:  2020-05-01

6.  Cost-effectiveness analysis of hemodialysis plus hemoperfusion versus hemodialysis alone in adult patients with end-stage renal disease in China.

Authors:  Haiyin Wang; Huajie Jin; Wendi Cheng; Xiaoxiao Qin; Yashuang Luo; Xin Liu; Yuyan Fu; Gengru Jiang; Wei Lu; Chunlin Jin; Mark Pennington
Journal:  Ann Transl Med       Date:  2021-07

Review 7.  Evaluation of Advanced Therapy Medicinal Products by the National Institute for Health and Care Excellence (NICE): An Updated Review.

Authors:  Ana-Catarina Pinho-Gomes; John Cairns
Journal:  Pharmacoecon Open       Date:  2021-08-20

8.  Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  John D Lee; Nur A Kamaruzaman; Jenny N T Fung; Stephen M Taylor; Bradley J Turner; Julie D Atkin; Trent M Woodruff; Peter G Noakes
Journal:  J Neuroinflammation       Date:  2013-09-26       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.